- 2026-12-04
-
Tumor-educated platelet transcripts with the routine blood count outperform cancer antigen 125 for ovarian cancer detection, particularly in premenopausal women
08:38-08:46
Room 501
Best Oral
Speaker
-
TBD
17:10-17:25
Room 503
Mini Oral
Speaker
- 2026-12-05
-
10:55-11:55
Hall A
APOLLO 10 Symposium
APOLLO 10 Symposium: Precision Therapeutics in Ovarian Cancer
Moderator
- 2026-12-06
-
First-line niraparib maintenance therapy in BRCA wild-type, low-risk advanced ovarian cancer: the POLO trial
07:32-07:39
Room 502
Mini Oral
Speaker
-
Final survival outcomes of the OPEB-01/APGOT-OV4 trial and identify clinical and molecular determinants of durable benefit
08:00-08:07
Room 502
Mini Oral
Speaker
-
12:15-12:55
Hall B
Education Seminar
Education Seminar 3: New Horizons in Gynecologic Cancer Care
Moderator


